TableĀ 1.
Reference | Age (years) | Sex | Race | Bone | Duration (years) | New diagnosis | Atraumatic | Operation | Medication | Multiple organ involvement | Number of organs involved except for bone |
---|---|---|---|---|---|---|---|---|---|---|---|
2 | 55 | M | NA, not applicable | Vertebra | NA, not applicable | N | Y | Y | PSL | Y | 3 |
3 | 22 | M | Japanese | Phalange | 7 | N | Y | N | PSL+MTX | Y | 2 |
4 | 39 | F | Black | Joint | 0.08 | N | N | Y | PSL | Y | 2 |
5 | 31 | F | Black | Joint | 3 | N | N | Y | PSL | Y | 2 |
6 | 26 | M | Black | Vertebra | 2 | N | NA, not applicable | Y | PSL | Y | 1 |
7 | 27 | F | Black | Rib | 0 | Y | N | N | PSL | Y | 2 |
8 | 36 | F | Black | Phalange | 1 | N | NA, not applicable | Y | PSL | Y | 1 |
8 | 19 | M | Black | Joint | NA, not applicable | N | NA, not applicable | Y | None | NA, not applicable | NA, not applicable |
9 | 59 | F | NA | Phalange | 0 | Y | Y | N | PSL | N | 0 |
10 | 29 | M | Black | Phalange | 0 | Y | N | N | None | Y | 1 |
11 | 49 | F | Japanese | Phalange | 0 | Y | Y | Y | PSL | N | 0 |
11 | 35 | M | Japanese | Phalange | 6 | N | N | Y | None | Y | 2 |
11 | 43 | F | Japanese | Phalange | 32 | N | Y | Y | PSL | Y | 3 |
12 | 48 | F | NA | Phalange | 0 | Y | Y | Y | PSL | N | 0 |
13 | 25 | F | Moroccan | Phalange | 2 | N | Y | Y | None | Y | 2 |
14 | 59 | F | Japanese | Phalange | 0.5 | N | Y | Y | None | Y | 1 |
15 | 38 | F | Black | Phalange | 12 | N | Y | Y | PSL | Y | 2 |
16 | 45 | F | Portugese | Femur, Ulna | 0 | Y | NA, not applicable | Y | None | N | 0 |
17 | 55 | M | Japanese | Vertebra | 3 | N | Y | Y | PSL | Y | 2 |
18 | 34 | M | Japanese | Phalange | 0 | Y | N | Y | PSL | Y | 6 |
19 | 36 | F | NA, not applicable | Vertebra | 0.9 | N | Y | N | PSL+CQ | Y | 3 |
20 | 52 | F | NA, not applicable | Phalange | 0 | Y | Y | Y | PSL | Y | 4 |
21 | 15 | F | Japanese | Phalange | 2 | N | Y | Y | PSL | Y | 2 |
Present case | 30 | M | Japanese | Joint, Phalange | 2 | N | Y | Y | PSL | Y | 5 |